The clearest signal on the Egyptian stock exchange today did not come from the heavyweight banks but from healthcare: Pharco Pharmaceuticals, identified here as PRCL, surged 11.8% to EGP 17.3, the strongest gain on the board in a session where the EGX 30 index rose 0.79% to 47,651.6 points. That gap between a moderate benchmark rise and a double-digit jump in a defensive name says a lot about the current Egyptian market: with USD/EGP at 54.34 and Brent crude at $110.5 a barrel, investors are increasingly choosing between inflation protection, margin visibility and the ability to pass through higher costs.
Key figures
- EGX 30: 47,651.6, up 0.79%
- PRCL: +11.8% at EGP 17.3, top gainer of the day
- Market breadth: 25 advancers, 16 decliners, 3 unchanged
- FWRY led turnover with EGP 934.7 million
- USD/EGP: 54.34, Brent: $110.5 per barrel
Market context: a higher index, but sector rotation mattered more
Trading on Monday, April 6, 2026 ended with a fairly broad-based advance, with , against and . That positive breadth shows the EGX 30’s rise was not driven by a single heavyweight. But the composition of the gainers was even more revealing: ceramics with up , steel with up , diversified investment through at , and then defensive healthcare and consumer names such as up and up .